Literature DB >> 28606962

Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: a mechanism contributing to vascular remodelling and intimal hyperplasia in giant-cell arteritis.

Ester Planas-Rigol1, Nekane Terrades-Garcia1, Marc Corbera-Bellalta1, Ester Lozano1, Marco A Alba1, Marta Segarra1, Georgina Espígol-Frigolé1, Sergio Prieto-González1, José Hernández-Rodríguez1, Sara Preciado2, Rodolfo Lavilla2, Maria C Cid1.   

Abstract

BACKGROUND: Giant-cell arteritis (GCA) is an inflammatory disease of large/medium-sized arteries, frequently involving the temporal arteries (TA). Inflammation-induced vascular remodelling leads to vaso-occlusive events. Circulating endothelin-1 (ET-1) is increased in patients with GCA with ischaemic complications suggesting a role for ET-1 in vascular occlusion beyond its vasoactive function.
OBJECTIVE: To investigate whether ET-1 induces a migratory myofibroblastic phenotype in human TA-derived vascular smooth muscle cells (VSMC) leading to intimal hyperplasia and vascular occlusion in GCA. METHODS AND
RESULTS: Immunofluorescence/confocal microscopy showed increased ET-1 expression in GCA lesions compared with control arteries. In inflamed arteries, ET-1 was predominantly expressed by infiltrating mononuclear cells whereas ET receptors, particularly ET-1 receptor B (ETBR), were expressed by both mononuclear cells and VSMC. ET-1 increased TA-derived VSMC migration in vitro and α-smooth muscle actin (αSMA) expression and migration from the media to the intima in cultured TA explants. ET-1 promoted VSMC motility by increasing activation of focal adhesion kinase (FAK), a crucial molecule in the turnover of focal adhesions during cell migration. FAK activation resulted in Y397 autophosphorylation creating binding sites for Src kinases and the p85 subunit of PI3kinases which, upon ET-1 exposure, colocalised with FAK at the focal adhesions of migrating VSMC. Accordingly, FAK or PI3K inhibition abrogated ET-1-induced migration in vitro. Consistently, ET-1 receptor A and ETBR antagonists reduced αSMA expression and delayed VSMC outgrowth from cultured GCA-involved artery explants.
CONCLUSIONS: ET-1 is upregulated in GCA lesions and, by promoting VSMC migration towards the intimal layer, may contribute to intimal hyperplasia and vascular occlusion in GCA. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  5-bisphosphate 3-kinase (PI3K); Giant-cell arteritis; Src kinase; cell migration; endothelin; extracellular signal -regulated kinase; focal adhesion kinase; matrix metaloproteinases. Heterotrimeric G proteins.; myofibroblast; phosphatidylinositol-4; vascular inflammation; vascularremodelling

Mesh:

Substances:

Year:  2017        PMID: 28606962     DOI: 10.1136/annrheumdis-2016-210792

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  19 in total

1.  Cyclic Tensile Strain Upregulates Pro-Inflammatory Cytokine Expression Via FAK-MAPK Signaling in Chondrocytes.

Authors:  Makoto Yanoshita; Naoto Hirose; Yuki Okamoto; Chikako Sumi; Mami Takano; Sayuri Nishiyama; Yuki Asakawa-Tanne; Kayo Horie; Azusa Onishi; Yuka Yamauchi; Tomomi Mitsuyoshi; Ryo Kunimatsu; Kotaro Tanimoto
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

Review 2.  Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities.

Authors:  Christian Dejaco; Elisabeth Brouwer; Justin C Mason; Frank Buttgereit; Eric L Matteson; Bhaskar Dasgupta
Journal:  Nat Rev Rheumatol       Date:  2017-09-14       Impact factor: 20.543

3.  An immunohistochemical analysis of folate receptor beta expression and distribution in giant cell arteritis - a pilot study.

Authors:  Shirley Albano-Aluquin; Jozef Malysz; Vincent R Aluquin; Manohar Ratnam; Nancy Olsen
Journal:  Am J Clin Exp Immunol       Date:  2017-12-20

Review 4.  Role of mitochondrial dynamics and mitophagy of vascular smooth muscle cell proliferation and migration in progression of atherosclerosis.

Authors:  Diem Thi Ngoc Huynh; Kyung-Sun Heo
Journal:  Arch Pharm Res       Date:  2021-11-07       Impact factor: 4.946

Review 5.  Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica.

Authors:  Kornelis S M van der Geest; Maria Sandovici; Pieter H Nienhuis; Riemer H J A Slart; Peter Heeringa; Elisabeth Brouwer; William F Jiemy
Journal:  Front Med (Lausanne)       Date:  2022-06-06

6.  Guanxinping Tablets Inhibit ET-1-Induced Proliferation and Migration of MOVAS by Suppressing Activated PI3K/Akt/NF-κB Signaling Cascade.

Authors:  Ying-Ying Wu; Yi-Lin Huang; Bin Dai; Jian-Wei Liu; Xu Han
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-31       Impact factor: 2.650

Review 7.  Large-vessel vasculitis.

Authors:  Dan Pugh; Maira Karabayas; Neil Basu; Maria C Cid; Ruchika Goel; Carl S Goodyear; Peter C Grayson; Stephen P McAdoo; Justin C Mason; Catherine Owen; Cornelia M Weyand; Taryn Youngstein; Neeraj Dhaun
Journal:  Nat Rev Dis Primers       Date:  2022-01-06       Impact factor: 65.038

Review 8.  Highlights in clinical medicine-Giant cell arteritis, polymyalgia rheumatica and Takayasu's arteritis: pathogenic links and therapeutic implications.

Authors:  Antonio Giovanni Solimando; Angelo Vacca; Franco Dammacco
Journal:  Clin Exp Med       Date:  2021-11-06       Impact factor: 5.057

Review 9.  Mechanism and biomarkers in aortitis--a review.

Authors:  Benjamin Benhuri; Ammar ELJack; Bashar Kahaleh; Ritu Chakravarti
Journal:  J Mol Med (Berl)       Date:  2019-10-30       Impact factor: 4.599

10.  Expression and Function of IL12/23 Related Cytokine Subunits (p35, p40, and p19) in Giant-Cell Arteritis Lesions: Contribution of p40 to Th1- and Th17-Mediated Inflammatory Pathways.

Authors:  Georgina Espígol-Frigolé; Ester Planas-Rigol; Ester Lozano; Marc Corbera-Bellalta; Nekane Terrades-García; Sergio Prieto-González; Ana García-Martínez; Jose Hernández-Rodríguez; Josep M Grau; Maria C Cid
Journal:  Front Immunol       Date:  2018-04-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.